V. Koubi-Pick

Abstract CT240: Molecular screening for cancer treatment optimization (MOSCATO 01): a prospective molecular triage trial; Interim analysis of 420 patients

A. Eggermont, T. Baère, F. André, 2014 .

Molecular screening for cancer treatment optimization: MOSCATO 01 - A prospective molecular triage trial, interim results

A. Eggermont, T. Baère, F. André, 2013 .

Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01).

T. de Baère, F. André, G. Vassal, 2016, European Journal of Cancer.

Molecular screening for cancer treatment optimization: MOSCATO 01 - A prospective molecular triage trial, interim results

A. Eggermont, T. Baère, F. André, 2013 .

Long survival in a child with a mutated K27M-H3.3 pilocytic astrocytoma

J. Grill, C. Maurage, F. Escande, 2015, Annals of clinical and translational neurology.

Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?

J. Pignon, D. Planchard, J. Soria, 2014, Lung cancer.

Molecular screening for cancer treatment optimization (MOSCATO 01) in pediatric patients: First feasibility results of a prospective molecular stratification trial.

P. Varlet, T. Baère, S. Puget, 2014 .